Antistaphylococcal evaluation of indole-naphthalene hybrid analogs.


Journal

Drug design, development and therapy
ISSN: 1177-8881
Titre abrégé: Drug Des Devel Ther
Pays: New Zealand
ID NLM: 101475745

Informations de publication

Date de publication:
2019
Historique:
entrez: 23 1 2019
pubmed: 23 1 2019
medline: 19 6 2019
Statut: epublish

Résumé

Resistance developments against established antibiotics are an emerging problem for antibacterial therapies. Infections with

Identifiants

pubmed: 30666089
doi: 10.2147/DDDT.S184965
pii: dddt-13-275
pmc: PMC6331074
doi:

Substances chimiques

Anti-Bacterial Agents 0
Indoles 0
Naphthalenes 0
naphthalene 2166IN72UN
indole 8724FJW4M5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

275-283

Déclaration de conflit d'intérêts

Disclosure The authors report no conflicts of interest in this work.

Références

J Gen Microbiol. 1952 Feb;6(1-2):95-107
pubmed: 14927856
J Bacteriol. 2008 Jan;190(1):300-10
pubmed: 17951380
Infect Immun. 2010 Jun;78(6):2877-89
pubmed: 20212089
AORN J. 2010 May;91(5):599-606; quiz 607-9
pubmed: 20451002
JAMA. 2010 Jun 9;303(22):2260-4
pubmed: 20530779
Int J Antimicrob Agents. 2010 Dec;36 Suppl 2:S55-7
pubmed: 21129922
Bioorg Med Chem Lett. 2011 Jun 1;21(11):3367-72
pubmed: 21524574
J Antibiot (Tokyo). 2012 Feb;65(2):53-7
pubmed: 22167161
Antimicrob Agents Chemother. 2014 Aug;58(8):4593-603
pubmed: 24867990
Int J Antimicrob Agents. 2014 Nov;44(5):377-86
pubmed: 25130096
Curr Opin Pharmacol. 2014 Oct;18:56-60
pubmed: 25254623
Evol Med Public Health. 2014 Oct 28;2014(1):147
pubmed: 25355275
P T. 2015 Apr;40(4):277-83
pubmed: 25859123
Mar Drugs. 2016 Jan 12;14(1):17
pubmed: 26771620
Mar Drugs. 2016 Jan 16;14(1):19
pubmed: 26784209
Lancet Respir Med. 2016 Mar;4(3):179
pubmed: 26895654
Sci Rep. 2016 Jul 11;6:29707
pubmed: 27405275
Nat Microbiol. 2017 Apr 03;2:17044
pubmed: 28368369
Biomolecules. 2018 Jan 19;8(1):
pubmed: 29351202
mSphere. 2018 May 2;3(3):
pubmed: 29720527
Nat Chem Biol. 2018 Jul;14(7):652-654
pubmed: 29915235

Auteurs

Kerolos Ashraf (K)

Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Halle, Germany, andreas.hilgeroth@pharmazie.uni-halle.de.

Kaveh Yasrebi (K)

Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Halle, Germany, andreas.hilgeroth@pharmazie.uni-halle.de.

Emmanuel Tola Adeniyi (ET)

Institute of Molecular Infection Biology, Julius Maximilians University Würzburg, Würzburg, Germany.

Tobias Hertlein (T)

Institute of Molecular Infection Biology, Julius Maximilians University Würzburg, Würzburg, Germany.

Knut Ohlsen (K)

Institute of Molecular Infection Biology, Julius Maximilians University Würzburg, Würzburg, Germany.

Michael Lalk (M)

Institute of Biochemistry, Ernst Moritz Arndt University Greifswald, Greifswald, Germany.

Frank Erdmann (F)

Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Halle, Germany, andreas.hilgeroth@pharmazie.uni-halle.de.

Andreas Hilgeroth (A)

Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Halle, Germany, andreas.hilgeroth@pharmazie.uni-halle.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH